Related Articles
A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells Corrigendum in /10.3892/ol.2020.11303
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6‑diazo‑5‑oxo‑L‑norleucine and orlistat in colon cancer
Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids
The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells Corrigendum in /10.3892/ijo.2015.3265
Effect of PTEN loss on metabolic reprogramming in prostate cancer cells